Sky Centy Invt (SKYID) Stock Price, News & Analysis
Company Description
Sky Centy Invt (OTC: SKYID) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $223.5K.
SKYID stock has declined 63.9% over the past year. Shares last traded at $0.2100.
On a trailing twelve-month basis, Sky Centy Invt reported revenue of $76K with net income of -$117K. The company operates at a net profit margin of -153.6%.
This page provides a comprehensive overview of SKYID stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sky Centy Invt (SKYID) stock last traded at $0.2100. Over the past 12 months, the stock has lost 63.9%. At a market capitalization of $223.5K, SKYID is classified as a micro-cap stock with approximately 2.2M shares outstanding.
SKYID Rankings
Latest News
SEC Filings
Sky Centy Invt has filed 2 recent SEC filings, including 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on April 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SKYID SEC filings →
Financial Highlights
Sky Centy Invt generated $76K in revenue over the trailing twelve months, retaining a 32.1% gross margin, operating income reached -$117K (-152.8% operating margin), and net income was -$117K, reflecting a -153.6% net profit margin. The company generated $46K in operating cash flow. With a current ratio of 0.01, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
SKYID Company Profile & Sector Positioning
Sky Centy Invt (SKYID) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.